I will need to assemble a genome from two PE250 MiSeq runs generating a total of about 12 to 14 Gbp of sequence. Based on some preliminary alignments to genes I had previously cloned and sequenced this would, on average, be better than 10x coverage. Since I don't have access to or funds for time on a computer with sufficient RAM to run something like Velvet, I was looking at Gossamer as an assembler with low hardware resource requirements. My question is this. I may be able to configure a VM for a short amount of time and I am wondering what would be a reasonable amount of vRAM and minimum number of CPU cores to get the assembly done in a reasonable time period.
-
-
I missed this somehow, but the Gossamer readme file says:
"Mammalian size genomes have been assembled using goss on a 32 GB Ubuntu machine."
So, since the genome I'll be assembling is about 1 Gbp, I should think that 32 GB of vRAM should be sufficient. If anyone has experience assembling with Gossamer, would there be any advantage to try and up that to 64 GB of RAM?Last edited by lkral; 02-22-2013, 05:56 PM. -
Mac vs Linux computer for MiSeq
Hello,
Can anyone tell if a MacPro is good enough for a basic MiSeq application anaysis?
I found one at apple.com
Mac Pro: 12-Core
Item Price: $4,649.00 Quantity (Mac Pro: 12-Core) Line Price:$4,649.00
Remove (Mac Pro: 12-Core) Save (Mac Pro: 12-Core)
Part number: Z0P2
Available to ship: 2-4 business days
Hardware
Two 2.40GHz 6-Core Intel Xeon processors (12 cores)
32GB (8x4GB)
2TB 7200-rpm Serial ATA 3Gb/s hard drive
ATI Radeon HD 5770 1GB
Is this good enough?
Thanks,Comment
-
Tumors contain complex mixtures of cell populations that evolve in response to treatment and host-specific factors. Tissue biopsies provide only static snapshots of a tumor’s state. But what if we could follow that evolution over time using a minimally invasive technique?
Liquid biopsies can detect tumor-derived material circulating in the bloodstream, providing a way to study treatment response, detect emerging resistance, and discover new biomarkers. Circulating...10-14-2026, 09:55 AM -
Researchers using sequencing and genomics tools often have to make trade-offs. They can choose between speed or scale, short reads or long-range information, or targeted panels or a view of the whole transcriptome. New technologies that have been released this year are built to address those tough choices.
We asked six companies the same four questions to learn about their latest products. The new technologies bring a lot to the table, including rethinking sequencing...
Comment